Editorial: Pharmaceutical policy, impact and health outcomes

被引：1
|
作者：
Kwon, Hye-Young [1 ]
Godman, Brian [2 ,3 ,4 ]
机构：
[1] Mokwon Univ, Div Biol & Publ Hlth, Daejeon, South Korea
[2] Sefako Makgatho Hlth Sci Univ, Sch Pharm, Dept Publ Hlth Pharm & Management, Pretoria, South Africa
[3] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow City, Scotland
[4] Ajman Univ, Ctr Med & Bioallied Hlth Sci Res, Ajman, U Arab Emirates
来源：
FRONTIERS IN PHARMACOLOGY | 2023年 / 14卷
关键词：
pharmaceutical policy; non-communicable diseases; cancer; cost-effectiveness; polypharmacy; procurement policies; impact; health outcomes; INHIBITORS;
D O I：
10.3389/fphar.2023.1150055
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
12345